Arkolith/Insider Trading/ITRM/Form 4

Dunne Michael W.

DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Sep 9, 2022
Net Buying
Open-Market Buys
$22K
Open-Market Sells
$0
Net Open-Market Flow
$22K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 7, 2022Buy(P)10K$2.22$22K36K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-049352) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML